{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:52:11Z","timestamp":1791035531302,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":84,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004795.pub3","type":"reference-entry","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T01:11:33Z","timestamp":1202260293000},"source":"Crossref","is-referenced-by-count":29,"title":["Fluoroquinolones for treating tuberculosis"],"prefix":"10.1002","author":[{"given":"Lilia E","family":"Ziganshina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B","family":"Squire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD004795.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/rccm.200603-360OC","article-title":"Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis","volume":"174","author":"Burman","year":"2006","journal-title":"American Journal of Respiratory & Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004795.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/520275","article-title":"Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG)","volume":"26","author":"El-Sadr","year":"1998","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004795.pub3-BIB3|cit3","first-page":"302","article-title":"Observation of the clinical efficacy of sparfloxacin in the treatment of multiple drug resistance pneumonial tuberculosis","volume":"25","author":"Huang","year":"2000","journal-title":"Chinese Journal of Antibiotics"},{"issue":"7","key":"10.1002\/14651858.CD004795.pub3-BIB4|cit4","first-page":"32","article-title":"Short-term observating of curative effects in treatment of multiple-drug resistance pulmonary tuberculosis with sparfloxacin and ofloxacin","volume":"24","author":"Ji","year":"2001","journal-title":"Journal of Postgraduates of Medicines"},{"issue":"6","key":"10.1002\/14651858.CD004795.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jac\/32.6.897","article-title":"Safety profile of ciprofloxacin during long-term therapy for pulmonary tuberculosis","volume":"32","author":"Kennedy","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD004795.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/clinids\/22.5.827","article-title":"Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis","volume":"22","author":"Kennedy","year":"1996","journal-title":"Clinical Infectious Diseases"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD004795.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1547","article-title":"Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis","volume":"148","author":"Kennedy","year":"1993","journal-title":"American Review of Respiratory Disease"},{"issue":"6","key":"10.1002\/14651858.CD004795.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1378\/chest.102.6.1815","article-title":"Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis","volume":"102","author":"Kohno","year":"1992","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD004795.pub3-BIB9|cit9","first-page":"50","article-title":"Antituberculosis effect of levofloxacin","volume":"23","author":"Lu","year":"2000","journal-title":"Zhonghua Jiehe He Huxi Zazhi [Chinese Journal of Tuberculosis and Respiratory Diseases]"},{"issue":"4","key":"10.1002\/14651858.CD004795.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1378\/chest.104.4.1194","article-title":"Controlled trial of ciprofloxacin in short-term chemotherapy for pulmonary tuberculosis","volume":"104","author":"Mohanty","year":"1993","journal-title":"Chest"},{"issue":"9","key":"10.1002\/14651858.CD004795.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1046\/j.1440-1746.2001.02570.x","article-title":"Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report","volume":"16","author":"Saigal","year":"2001","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD004795.pub3-BIB12|cit12","first-page":"52","article-title":"A randomized controlled study of sparfloxacin and ofloxacin in the treatment of multiple drug resistant pulmonary tuberculosis","volume":"25","author":"Sun","year":"2000","journal-title":"Chinese Journal of Antibiotics"},{"issue":"5707","key":"10.1002\/14651858.CD004795.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1002\/14651858.CD004795.pub3-BIB14|cit14","first-page":"59","article-title":"A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service\/British Medical Research Council","volume":"73","author":"Anonymous","year":"1997","journal-title":"Tubercle and Lung Disease"},{"issue":"4","key":"10.1002\/14651858.CD004795.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1086\/513945","article-title":"Activity of amoxicillin\/clavulanate in patients with tuberculosis","volume":"26","author":"Chambers","year":"1998","journal-title":"Clinical Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD004795.pub3-BIB16|cit16","first-page":"454","article-title":"A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis","volume":"26","author":"Chen","year":"2003","journal-title":"Zhonghua Jiehe He Huxi Zazhi [Chinese Journal of Tuberculosis and Respiratory Diseases]"},{"issue":"8","key":"10.1002\/14651858.CD004795.pub3-BIB17|cit17","first-page":"9","article-title":"Efficiency of a new standard chemotherapy regimen in the treatment of patients with recurrent pulmonary tuberculosis","author":"Chukanov","year":"2006","journal-title":"Problemy Tuberculeza I Boleznej Legkih"},{"issue":"1","key":"10.1002\/14651858.CD004795.pub3-BIB18|cit18","first-page":"64","article-title":"Treatment of urogenital tuberculosis with ofloxacin. Preliminary study","volume":"16","author":"Estebanez Zarranz","year":"1992","journal-title":"Actas Urologicas Espanolas"},{"issue":"11","key":"10.1002\/14651858.CD004795.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1164\/rccm.200305-682OC","article-title":"The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis","volume":"168","author":"Gosling","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"10","key":"10.1002\/14651858.CD004795.pub3-BIB20|cit20","first-page":"17","article-title":"Lomefloxacin in phthisiatric practice","volume":"43","author":"Grishin","year":"1998","journal-title":"Antibiotiki i Khimioterapiia"},{"issue":"6","key":"10.1002\/14651858.CD004795.pub3-BIB21|cit21","first-page":"605","article-title":"Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis","volume":"10","author":"Johnson","year":"2006","journal-title":"International Journal of Tuberculosis & Lung Disease"},{"issue":"10","key":"10.1002\/14651858.CD004795.pub3-BIB22|cit22","first-page":"679","article-title":"Evaluation of new antitubercular agents--new quinolone agents","volume":"67","author":"Kawahara","year":"1992","journal-title":"Kekkaku"},{"issue":"3","key":"10.1002\/14651858.CD004795.pub3-BIB23|cit23","first-page":"323","article-title":"Disposition of uric acid upon administration of ofloxacin alone and in combination with other anti-tuberculosis drugs","volume":"42","author":"Kumar","year":"2004","journal-title":"Indian Journal of Experimental Biology"},{"issue":"3","key":"10.1002\/14651858.CD004795.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1378\/chest.128.3.1406","article-title":"Levofloxacin treatment of active tuberculosis and the risk of adverse events","volume":"128","author":"Marra","year":"2005","journal-title":"Chest"},{"issue":"4","key":"10.1002\/14651858.CD004795.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1378\/chest.106.4.1312","article-title":"Ciprofloxacin is not a component of first-line TB","volume":"106","author":"O'Brien","year":"1994","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD004795.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/AAC.48.3.780-782.2004","article-title":"Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study","volume":"48","author":"Pletz","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD004795.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1164\/ajrccm.156.3.9611066","article-title":"The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis","volume":"156","author":"Sirgel","year":"1997","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004795.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/jac\/45.6.859","article-title":"A multicentre study of the early bactericidal activity of anti-tuberculosis drugs","volume":"45","author":"Sirgel","year":"2000","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD004795.pub3-BIB29|cit29","first-page":"10","article-title":"Lomefloxacin in complex treatment of acute progressive form of pulmonary tuberculosis","volume":"43","author":"Sokolova","year":"1998","journal-title":"Antibiotiki i Khimioterapiia"},{"key":"10.1002\/14651858.CD004795.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000239510","article-title":"Treatment of multidrug-resistant tuberculosis in Taiwan","volume":"42 Suppl 3","author":"Suo","year":"1996","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD004795.pub3-BIB31|cit31","first-page":"27","article-title":"Shortening short course chemotherapy: a randomized clinical trial for treatment of smear positive pulmonary tuberculosis with regimens using ofloxacin in the intensive phase","volume":"49","author":"Chennei","year":"2002","journal-title":"Indian Journal of Tuberculosis"},{"issue":"1","key":"10.1002\/14651858.CD004795.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1179\/joc.2003.15.1.66","article-title":"Long-term tolerance and effectiveness of moxifloxacin therapy for tuberculosis: preliminary results","volume":"15","author":"Valerio","year":"2003","journal-title":"Journal of Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD004795.pub3-BIB33|cit33","first-page":"62","article-title":"Adrenocortical function in hospitalised patients with active pulmonary tuberculosis receiving a rifampicin-based regimen - a pilot study","volume":"96","author":"Venter","year":"2006","journal-title":"South African Medical Journal"},{"issue":"10","key":"10.1002\/14651858.CD004795.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/thx.2005.056887","article-title":"Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas","volume":"61","author":"Wang","year":"2006","journal-title":"Thorax"},{"issue":"11","key":"10.1002\/14651858.CD004795.pub3-BIB35|cit35","first-page":"1215","article-title":"Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia","volume":"9","author":"Yoon","year":"2005","journal-title":"International Journal of Tuberculosis & Lung Disease"},{"issue":"6","key":"10.1002\/14651858.CD004795.pub3-BIB36|cit36","first-page":"354","article-title":"Bronchofiberscope and catheter intervention in treatment of multi-drug resistant pulmonary tuberculosis","volume":"20","author":"Zhang","year":"1997","journal-title":"Zhonghua Jiehe He Huxi Zazhi [Chinese Journal of Tuberculosis and Respiratory Diseases]"},{"issue":"4","key":"10.1002\/14651858.CD004795.pub3-BIB37|cit37","first-page":"223","article-title":"Clinic assessment of rifabutin in the treatment of multidrug-resistant pulmonary tuberculosis","volume":"31","author":"Zhang","year":"2006","journal-title":"Chinese Journal of Antibiotics"},{"issue":"8","key":"10.1002\/14651858.CD004795.pub3-BIB38|cit38","first-page":"497","article-title":"Therapeutic effects of levofloxacin-containing regimen in patients with retreated pulmonary tuberculosis","volume":"28","author":"Zhao","year":"2003","journal-title":"Chinese Journal of Antibiotics"},{"issue":"5","key":"10.1002\/14651858.CD004795.pub3-BIB39|cit39","first-page":"574","article-title":"Short-term effect of treatment protocol utilizing levofloxacin, pasiniazide and M.Vaccae on multi-drug resistant pulmonary tuberculosis","volume":"24","author":"Zheng","year":"2004","journal-title":"Di Yi Jun Yi Da Xue Xue Bao [Academic Journal of the First Medical College of PLA]"},{"issue":"8","key":"10.1002\/14651858.CD004795.pub3-BIB40|cit40","first-page":"520","article-title":"A controlled clinical trial of long course chemotherapy regimens containing rifabutin in the treatment of multi-drug resistant pulmonary tuberculosis","volume":"29","author":"Zhu","year":"2006","journal-title":"Chinese Journal of Tuberculosis & Respiratory Diseases"},{"key":"10.1002\/14651858.CD004795.pub3-BIB41|cit41","first-page":"25214","article-title":"Ofloxacin in the treatment of primary drug resistant pulmonary tuberculosis (PDR-TB)","volume":"10 Suppl","author":"Abdullah","year":"1997","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD004795.pub3-BIB42|cit42","first-page":"28367","article-title":"Ofloxacin dosage in the treatment of multidrug resistant pulmonary tuberculosis (MDR-TB)","volume":"12 Suppl","author":"Abdullah","year":"1998","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD004795.pub3-BIB43|cit43","unstructured":"ISRCTN 07062956 A randomised comparison of ciprofloxacin, levofloxacin and gatifloxacin for the treatment of adults with tuberculous meningitis www.controlled-trials.com\/ISRCTN07062956\/07062956"},{"key":"10.1002\/14651858.CD004795.pub3-BIB44|cit44","unstructured":"ISRCTN13670619 A comparative study of the bactericidal and sterilizing activity of three fluoroquinolones: gatifloxacin, moxifloxacin and ofloxacin substituted for ethambutol in the 2 month initial phase of the standard anti-tuberculosis treatment regimen also containing rifampicin, isoniazid and pyrazinamide (South Africa) www.controlled-trials.com\/ISRCTN13670619\/ISRCTN13670619"},{"key":"10.1002\/14651858.CD004795.pub3-BIB45|cit45","unstructured":"ISRCTN44153044 An international multicentre controlled clinical trial to evaluate high dose RIFApentine and a QUINolone in the treatment of pulmonary tuberculosis www.controlled-trials.com\/ISRCTN44153044\/ISRCTN44153044"},{"key":"10.1002\/14651858.CD004795.pub3-BIB46|cit46","unstructured":"ISRCTN85595810 Controlled comparison of two moxifloxacin containing treatment shortening regimens in pulmonary tuberculosis www.controlled-trials.com\/mrct\/trial\/260713\/REMoxTB"},{"key":"10.1002\/14651858.CD004795.pub3-BIB47|cit47","unstructured":"NCT00144417 Evaluation of a moxifloxacin-based, isoniazid-sparing regimen for tuberculosis treatment www.clinicaltrials.gov\/show\/NCT00144417"},{"key":"10.1002\/14651858.CD004795.pub3-BIB48|cit48","unstructured":"NCT00216385 A controlled trial of a 4-month quinolone-containing regimen for the treatment of pulmonary tuberculosis clinicaltrials-nccs.nlm.nih.gov\/ct2\/show\/NCT00216385"},{"key":"10.1002\/14651858.CD004795.pub3-BIB49|cit49","unstructured":"NCT00396084 Randomized, open label, multiple dose Phase I study of the early bactericidal activity of linezolid, gatifloxacin, levofloxacin, and moxifloxacin in HIV-non-infected adults with Initial episodes of sputum smear-positive pulmonary tuberculosis (DMID 01-553) clinicaltrials.gov\/ct\/show\/NCT00396084?order=11"},{"issue":"5","key":"10.1002\/14651858.CD004795.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/516116","article-title":"The clinical use of fluoroquinolones for the treatment of mycobacterial diseases","volume":"25","author":"Alangaden","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD004795.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0041-3879(83)90011-9","article-title":"Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis","volume":"64","author":"Anonymous","year":"1983","journal-title":"Tubercle"},{"issue":"4","key":"10.1002\/14651858.CD004795.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"American Journal of Respiratory Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004795.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1086\/515174","article-title":"Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis","volume":"28","author":"Burman","year":"1999","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD004795.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1164\/rccm.200308-1159OC","article-title":"Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis","volume":"169","author":"Chan","year":"2004","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"9","key":"10.1002\/14651858.CD004795.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett","year":"2003","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004795.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJM199201233260404","article-title":"An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms","volume":"326","author":"Daley","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004795.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/318706","article-title":"A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes","volume":"32","author":"El-Sadr","year":"2001","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004795.pub3-BIB58|cit58","first-page":"265","article-title":"Fluoroquinolones: a new treatment for tuberculosis?","volume":"2","author":"Gillespie","year":"1998","journal-title":"International Journal Tuberculosis Lung Disease"},{"issue":"7","key":"10.1002\/14651858.CD004795.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1473-3099(03)00671-6","article-title":"Fluoroquinolones, tuberculosis, and resistance","volume":"3","author":"Ginsburg","year":"2003","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD004795.pub3-BIB60|cit60","unstructured":"Grzybowski S Barnett GD Styblo K Contacts of cases of active pulmonary tuberculosis Bulletin of the International Union Against Tuberculosis 1975 90 106"},{"key":"10.1002\/14651858.CD004795.pub3-BIB61|cit61","unstructured":"Higgins JPT Green S Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Appendix 5b www.cochrane.org\/resources\/handbook\/hbook.htm"},{"key":"10.1002\/14651858.CD004795.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00003495-199958002-00004","article-title":"Activity of quinolones against mycobacteria","volume":"58 Suppl 2","author":"Jacobs","year":"1999","journal-title":"Drugs"},{"issue":"7303","key":"10.1002\/14651858.CD004795.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: Assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD004795.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-3879(91)90017-M","article-title":"The global tuberculosis situation and the new control strategy of the World Health Organization","volume":"72","author":"Kochi","year":"1991","journal-title":"Tubercle"},{"key":"10.1002\/14651858.CD004795.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1183\/09031936.02.00401302","article-title":"Strategies against multidrug-resistant tuberculosis","volume":"30 Suppl","author":"Loddenkemper","year":"2002","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD004795.pub3-BIB66|cit66","first-page":"1881","volume-title":"Martindale: the extra pharmacopoeia","author":"Reynolds","year":"1996"},{"key":"10.1002\/14651858.CD004795.pub3-BIB67|cit67","unstructured":"Pablos-Mendez A Gowda DK Frieden TR Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework Bulletin of the World Health Organization 2002 489 95"},{"issue":"7","key":"10.1002\/14651858.CD004795.pub3-BIB68|cit68","first-page":"582","article-title":"Addressing multidrug-resistant tuberculosis in penitentiary hospitals and in the general population of the former Soviet Union","volume":"3","author":"Portaels","year":"1999","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1002\/14651858.CD004795.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000239506","article-title":"Multidrug resistance in the world: the present situation","volume":"42 Suppl 3","author":"Reichman","year":"1996","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD004795.pub3-BIB70|cit70","unstructured":"The Nordic Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"6","key":"10.1002\/14651858.CD004795.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0962-8479(95)90537-5","article-title":"Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient","volume":"76","author":"Shafer","year":"1995","journal-title":"Tubercle and Lung Disease"},{"issue":"2","key":"10.1002\/14651858.CD004795.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0041-3879(81)90016-7","article-title":"Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30 months","volume":"62","author":"Anon","year":"1981","journal-title":"Tubercule"},{"issue":"4","key":"10.1002\/14651858.CD004795.pub3-BIB73|cit73","first-page":"337","article-title":"Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health","volume":"3","author":"Telzak","year":"1999","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"1","key":"10.1002\/14651858.CD004795.pub3-BIB74|cit74","first-page":"53","article-title":"A randomized controlled study of sparfloxacin and ofloxacin in the treatment of multiple drug resistant pulmonary tuberculosis","volume":"25","author":"Wei","year":"2000","journal-title":"Chinese Journal of Antibiotics"},{"key":"10.1002\/14651858.CD004795.pub3-BIB75|cit75","first-page":"13","volume-title":"Treatment of tuberculosis: guidelines for national programmes [WHO\/CDS\/TB\/2003.313]","year":"2003"},{"key":"10.1002\/14651858.CD004795.pub3-BIB76|cit76","first-page":"38","volume-title":"Guidelines for the programmatic management of drug-resistant tuberculosis [WHO\/HTM\/TB\/2006.361]","year":"2006"},{"key":"10.1002\/14651858.CD004795.pub3-BIB77|cit77","unstructured":"World Health Organization. Stop TB Dept Global tuberculosis control : surveillance, planning, financing : WHO report 2007 [WHO\/HTM\/TB\/2007.376] http:\/\/www.who.int\/tb\/publications\/global_report\/2007\/download_centre\/en\/index.html"},{"key":"10.1002\/14651858.CD004795.pub3-BIB78|cit78","unstructured":"World Health Organization Fact Sheet No 104: Tuberculosis www.who.int\/mediacentre\/factsheets\/fs104\/en\/index.html"},{"issue":"2","key":"10.1002\/14651858.CD004795.pub3-BIB79|cit79","first-page":"95","article-title":"WHO model list of essential medicines: 15th edition, revised March 2007","volume":"21","year":"2007","journal-title":"WHO Drug Information"},{"issue":"1","key":"10.1002\/14651858.CD004795.pub3-BIB80|cit80","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","author":"Woldehanna","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004795.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1378\/chest.117.3.744","article-title":"Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin\/levofloxacin-containing regimens","volume":"117","author":"Yew","year":"2000","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD004795.pub3-BIB82|cit82","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00002018-200225020-00005","article-title":"Clinically significant interactions with drugs used in the treatment of tuberculosis","volume":"25","author":"Yew","year":"2001","journal-title":"Drug Safety"},{"issue":"4","key":"10.1002\/14651858.CD004795.pub3-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1378\/chest.124.4.1476","article-title":"Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong","volume":"124","author":"Yew","year":"2003","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD004795.pub3-BIB84|cit84","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004795.pub2","article-title":"Fluoroquinolones for treating tuberculosis","author":"Ziganshina","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004795.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T00:00:00Z","timestamp":1370476800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004795.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:40:08Z","timestamp":1628545208000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004795.pub3"}},"subtitle":[],"editor":[{"given":"Lilia E","family":"Ziganshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":84,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004795.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004795.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2008,1,23]]}}}